Safety and Immunogenicity of a New Formulation of Euvichol®

PHASE3UnknownINTERVENTIONAL
Enrollment

442

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions
Cholera
Interventions
BIOLOGICAL

Test Oral Cholera Vaccine

Thimerosal free, manufactured at 600 L scale killed bivalent (O1 and O139) whole cell-oral cholera vaccine (WC-OCV) manufactured by Eubiologics Co., Ltd.

BIOLOGICAL

Euvichol®

Licensed, manufactured at 100 L scale killed bivalent (O1 and O139) whole cell-oral cholera vaccine (WC-OCV) manufactured by Eubiologics Co., Ltd.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

EuBiologics Co.,Ltd

INDUSTRY

lead

International Vaccine Institute

OTHER

NCT02502331 - Safety and Immunogenicity of a New Formulation of Euvichol® | Biotech Hunter | Biotech Hunter